Survey finds wide variation in NICU hsPDA guidelines

A survey of 44 Children's Hospitals Neonatal Consortium centers found that 67% had written guidelines for hemodynamically significant patent ductus arteriosus (hsPDA), with 72% specifying clinical signs and 84% specifying echocardiographic criteria. The survey reported that ibuprofen was the most common first-line pharmacotherapy, followed by acetaminophen and indomethacin, and that most centers used a stepwise approach including fluid restriction, diuretics, pharmacotherapy, and transcatheter closure, with surgical ligation recommended less often. The authors stated this highlights evolving practice patterns in neonatal PDA care.

Most relevant for: Clinicians managing hemodynamically significant patent ductus arteriosus in neonatal intensive care units.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.